[1]彭琼琳,黄 敏.超声消融结合中药治疗子宫腺肌病继发性痛经的效果[J].医学信息,2021,34(17):157-159.[doi:10.3969/j.issn.1006-1959.2021.17.042]
　PENG Qiong-lin,HUANG Min.The Effect of Ultrasonic Ablation Combined with Traditional Chinese Medicine in the Treatment of Secondary Dysmenorrhea Caused by Adenomyosis[J].Medical Information,2021,34(17):157-159.[doi:10.3969/j.issn.1006-1959.2021.17.042]
点击复制

超声消融结合中药治疗子宫腺肌病继发性痛经的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年17期
页码:
157-159
栏目:
中医中药
出版日期:
2021-09-01

文章信息/Info

Title:
The Effect of Ultrasonic Ablation Combined with Traditional Chinese Medicine in the Treatment of Secondary Dysmenorrhea Caused by Adenomyosis
文章编号:
1006-1959（2021）17-0157-03
作者:
彭琼琳; 黄 敏
（鄂钢医院妇产科，湖北 鄂州 436000）
Author(s):
PENG Qiong-lin; HUANG Min
(Department of Obstetrics and Gynecology,Egang Hospital,Ezhou 436000,Hubei,China)
关键词:
当归芍药散; 子宫腺肌病; 继发性痛经; 超声消融; 激素水平
Keywords:
Danggui Shaoyao San; Adenomyosis; Secondary dysmenorrhea; Ultrasound ablation; Hormone levels
分类号:
R246.3
DOI:
10.3969/j.issn.1006-1959.2021.17.042
文献标志码:
A
摘要:
目的 探讨超声消融联合当归芍药散加减治疗子宫腺肌病继发性痛经的临床疗效。方法 选取2018年5月-2019年1月我院收治的子宫腺肌病继发性痛经患者124例为研究对象，采用随机数字表法分为对照组和观察组，各62例。对照组采用超声消融联合左炔诺孕酮宫内缓释节育系统治疗，观察组在对照组基础上加服当归芍药散，比较两组治疗后血清雌二醇（E2）、前列腺素F2α（PGF2α）水平、子宫体积、病灶体积、月经量评分、痛经评分（VAS）、痊愈率、不良反应发生率及1年后复发率。结果 治疗后6、12个月，观察组E2和PGF2α低于对照组（P＜0.05）；观察组月经量评分、子宫体积和病灶体积均低于对照组（P＜0.05）；观察组VAS评分、轻度和重度痛经率均低于对照组（P＜0.05）；观察组不良反应发生率和1年随访复发率低于对照组，痊愈率高于对照组（P＜0.05）。结论 当归芍药散可调节子宫腺肌病继发性痛经患者E2和PGF2α等激素水平，加减该方剂可改善超声消融术术后子宫腺肌病继发性痛经的临床症状并降低复发率。
Abstract:
Objective To explore the clinical effect of ultrasonic ablation combined with Danggui Shaoyao San in the treatment of dysmenorrhea secondary to adenomyosis.Methods Totally 124 patients with secondary dysmenorrhea caused by adenomyosis admitted to our hospital from May 2018 to January 2019 were selected as the research objects.Using random number table method, they were divided into control group and observation group, each with 62 cases.The control group was treated with ultrasound ablation combined with levonorgestrel sustained-release intrauterine birth control system, and the observation group was treated with Danggui Shaoyao San on the basis of the control group.Comparison of serum estradiol (E2), prostaglandin F2α (PGF2α) levels, uterine volume, lesion volume, menstrual volume score, dysmenorrhea score (VAS), recovery rate, adverse reaction rate, and recurrence rate after 1 year between the two groups after treatment.Results At 6 and 12 months after treatment,E2 and PGF2α in the observation group were lower than those in the control group(P<0.05);The menstrual volume score, uterine volume and lesion volume of the observation group were lower than those of the control group(P<0.05);The VAS score and the rates of mild and severe dysmenorrhea in the observation group were lower than those in the control group(P<0.05);The incidence of adverse reactions and the recurrence rate of one-year follow-up in the observation group were lower than those in the control group, and the recovery rate was higher than that in the control group(P<0.05).Conclusion Danggui Shaoyao San can adjust the levels of hormones such as E2 and PGF2α in patients with secondary dysmenorrhea of adenomyosis. Adding or subtracting this prescription can improve the clinical symptoms of secondary dysmenorrhea caused by adenomyosis after ultrasonic ablation and reduce the recurrence rate.

参考文献/References:

[1]张晓丽,李晶晶,谭广萍,等.腹腔镜病灶切除术后联合药物序贯治疗子宫腺肌病的效果[J].医学信息,2020,33(3):102-104. [2]Xia W,Zhang D,Ouyang J,et al.Effects of pelvic endometriosis and adenomyosis on ciliary beat frequency and muscular contractions in the human fallopian tube[J].Reprod Biol Endocrinol,2018,16(1):48-51. [3]马荣丽,关铮,刘爱军,等.前列腺素F(2α)受体与子宫腺肌病痛经的相关性研究[J].解放军医学院学报,2015,15(4):355-358. [4]李旭升,洪丽霞,金庆跃,等.子宫平滑肌前列腺素E2受体分布与复发性自然流产发病机制的相关性研究[J].浙江医学2018,40(7):676-679. [5]罗爽,王艳,何佳,等.高强度聚焦超声消融联合孕三烯酮治疗子宫腺肌病的疗效评价[J].重庆医学,2018,47(2):170-172. [6]毛常峰,王慧霞.门成福应用《金匮要略》妇科三方经验概要[J].中医学报,2018,12(4):577-580. [7]刘国云,迟晓丽,马渊,等.当归芍药散活性部位DSS-A-N-30对大鼠离体子宫平滑肌收缩的影响[J].中国药理学与毒理学杂志,2007,21(5):427-433. [8]乐杰.妇产科学[M].第7版.北京:人民卫生出版社,2011:318-319. [9]Zhang X,Li KQ,Xie B,et al.Effective ablation therapy of adenomyosis with ultrasound—guided high—intensity focused ultrasound[J].Int J Gynaecol Obstet,2014,124(3):207-211. [10]杨霞,陈亚兰.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].医学信息,2019,32(14):117-118. [11]张越.当归芍药散治疗原发性痛经的临床观察[J].北方药学,2018,15(2):87. [12]罗茜,兰培敏,彭旭,等.当归芍药散治疗女性黄褐斑疗效及对性激素水平的影响[J].现代中西医结合杂志,2019,28(11):1188-1191.

相似文献/References:

[1]翟 蓓,周 洋,周 薇,等.超声检查、磁共振及血清CA125测定诊断 子宫腺肌病的临床评价[J].医学信息,2018,31(11):154.[doi:10.3969/j.issn.1006-1959.2018.11.050]
　ZHAI Bei,ZHOU Yang,ZHOU Wei,et al.Clinical Evaluation of Ultrasonography,Magnetic Resonance Imaging and Serum CA125 in Diagnosis of Adenomyosis[J].Medical Information,2018,31(17):154.[doi:10.3969/j.issn.1006-1959.2018.11.050]
[2]杨 霞,陈亚兰.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].医学信息,2019,32(14):117.[doi:10.3969/j.issn.1006-1959.2019.14.037]
　YANG Xia,CHEN Ya-lan.Clinical Observation of Levonorgestrel Intrauterine Sustained Release System in the Treatment of Adenomyosis[J].Medical Information,2019,32(17):117.[doi:10.3969/j.issn.1006-1959.2019.14.037]
[3]张晓丽,李晶晶,谭广萍,等.腹腔镜病灶切除联合序贯使用亮丙瑞林及优思明在子宫腺肌病中的应用[J].医学信息,2020,33(03):102.[doi:10.3969/j.issn.1006-1959.2020.03.029]
　ZHANG Xiao-li,LI Jing-jing,TAN Guang-ping,et al.The Effect of Sequential Drug Treatment on Adenomyosis After Laparoscopic Focal Resection[J].Medical Information,2020,33(17):102.[doi:10.3969/j.issn.1006-1959.2020.03.029]
[4]李 娟,胡 欣,张小妹.米非司酮联合血府逐瘀汤治疗子宫腺肌病的临床观察[J].医学信息,2021,34(23):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
　LI Juan,HU Xin,ZHANG Xiao-mei.Clinical Observation of Mifepristone Combined with Xuefu Zhuyu Decoction in the Treatment of Adenomyosis[J].Medical Information,2021,34(17):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
[5]彭琼琳,黄 敏.高强度聚焦超声消融联合当归芍药散治疗子宫腺肌病的疗效分析[J].医学信息,2022,35(01):133.[doi:10.3969/j.issn.1006-1959.2022.01.032]
　PENG Qiong-lin,HUANG Min.Efficacy of High-intensity Focused Ultrasound Ablation Combined with Danggui Shaoyao Powder in the Treatment of Adenomyosis[J].Medical Information,2022,35(17):133.[doi:10.3969/j.issn.1006-1959.2022.01.032]

更新日期/Last Update: 1900-01-01